Pharm-Olam names new CEO, Dr. Robert Davie

Pharm-Olam appoints former Covance executive Robert Davie, Ph.D., as CEO to succeed David Grange and continue Pharm-Olam’s growth and support of clinical drug development as a premier CRO.